🔎 Trials Near Me

Hjem › Overvægt › Texas › Houston

Overvægt kliniske forsøg i Houston, TX

33 studier for Overvægt søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi væk
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekruttererFase 3
  • PlanIt Research, PLLC, Houston
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

RekruttererFase 3
  • DM Clinical, Houston
Alder 8 til 18 · Alle køn · Opdateret 30. sep. 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RekruttererFase 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • og 1 flere
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Juno Research, Houston
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • Juno Research, Houston
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, Houston
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • og 2 flere
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi væk
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi væk
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • PlanIt Research, PLLC, Houston
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

RekruttererFase 2Frivillige med god helbredstilstand velkomne
  • The University of Texas Health Science Center at Houston, Houston
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Houston
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RekruttererFase 2
  • Juno Research, Houston
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi væk
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekruttererFase 3Frivillige med god helbredstilstand velkomne
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Alder 18 til 79 · Alle køn · Opdateret 11. sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • PlanIt Research, PLLC, Houston
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

RekruttererFase 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi væk
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi væk
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Bellaire · 7 mi væk
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RekruttererFase 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi væk
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RekruttererFase 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Alder 18 til 99 · Alle køn · Opdateret 27. aug. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, Houston
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Alder 18 til 79 · Alle køn · Opdateret 10. aug. 2026 · NCT07654361

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

RekruttererFase 2
  • Baylor College of Medicine, Houston
Alder 18 og opefter · Alle køn · Opdateret 16. jan. 2026 · NCT06273072

Overvægt forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.